Vasopressin V1a and V1b receptor modulators: a patent review (2012 - 2014)

Expert Opinion on Therapeutic Patents
Magdalena J Ślusarz

Abstract

The vasopressin V1a and V1b receptors are involved in many crucial physiological, reproductive, behavioral and social functions. Consequently, they are also involved in several pathological conditions, thus the ligands capable of selective stimulation/inhibition of these receptors may present therapeutic benefit in a variety of diseases. In this review, the author focuses on the vasopressin V1a and V1b receptors, their biological functions and agonists and antagonists patented in the years 2012 - 2014. This paper is divided according to both the target receptor and the applicant and describes the compounds from the patents along with their biological activity. In the recent years, pharmaceutical companies have discovered and patented new compounds which act through vasopressin V1a and/or V1b receptors, both peptide and non-peptide. Among the V1bR antagonists published in the last years, the oxindole derivatives appear to be the most promising drug candidates.

References

Feb 15, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Aug 1, 1990·Circulation Research·E M Hasser, V S Bishop
Oct 1, 1988·Physiological Reviews·L Share
Jan 25, 1980·Science·M J BrownsteinH Gainer
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·S J LolaitM J Brownstein
Jul 11, 1995·The American Journal of Physiology·K NakanishiA W Cowley
Apr 1, 1993·Frontiers in Neuroendocrinology·F A Antoni
Jan 1, 1996·Critical Reviews in Neurobiology·C Barberis, E Tribollet
Feb 14, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C BernadichJ Bosch
Mar 31, 1998·The Journal of Endocrinology·C BarberisT Durroux
Oct 12, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F Holsboer
Apr 17, 2002·Lancet·Alastair O'BrienMervyn Singer
Dec 19, 2002·Emergency Medicine·Mark Barlow
Dec 21, 2002·Alimentary Pharmacology & Therapeutics·G N IoannouD C Rockey
Dec 24, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Remco F P de WinterJaap G Goekoop
Feb 1, 2003·Trends in Pharmacological Sciences·László HunyadyPatrick Vanderheyden
May 9, 2003·American Journal of Physiology. Endocrinology and Metabolism·Viviane FolnyClaudine Serradeil-Le Gal
Dec 1, 1952·British Journal of Pharmacology and Chemotherapy·J DEKANSKI
Apr 20, 2004·Journal of Neuroendocrinology·D Devost, H H Zingg
May 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Taka-aki KoshimizuGozoh Tsujimoto
May 24, 2006·Pharmacotherapy·Todd A Miano, Michael A Crouch
Aug 26, 2006·Anesthesiology·Tanja A Treschan, Jürgen Peters
Oct 6, 2006·Molecular Endocrinology·Masami HiroyamaAkito Tanoue
Jan 19, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Michihiko Iijima, Shigeyuki Chaki
Apr 13, 2007·Drugs·Farhan AliJalal K Ghali
Jul 20, 2007·Biochemical Society Transactions·B Chini, M Manning
Aug 19, 2007·Endocrinology·Roberto Arban
Feb 29, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Atsushi SanbeAkito Tanoue
May 2, 2008·American Journal of Physiology. Renal Physiology·Toshinori AoyagiAkito Tanoue
May 13, 2008·Gastroenterology·Arun J SanyalUNKNOWN Terlipressin Study Group
Mar 6, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Loren M DeVitoHoward Eichenbaum
Jul 10, 2009·American Journal of Physiology. Renal Physiology·Hasiyet MemetiminKimio Tomita
Sep 1, 2009·Expert Opinion on Investigational Drugs·Victoria D KirchhoffRoger S McIntyre
Sep 30, 2010·Pharmacotherapy·Seth R Bauer, Simon W Lam
Dec 17, 2010·World Journal of Hepatology·Salvador AugustinJoan Genescà
Apr 1, 2011·Kidney International·Peter A GrossGuy Decaux

❮ Previous
Next ❯

Citations

Oct 22, 2020·ACS Chemical Neuroscience·Ferenc BaskaImre Bata

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Therapeutic Patents
Luca Costantino, Daniela Barlocco
Expert Opinion on Therapeutic Patents
Irene Giorgi, Paola Nieri
Expert Opinion on Therapeutic Patents
Muhammad Jahangir HossenJae Youl Cho
Expert Opinion on Therapeutic Patents
Róbert Kiss, György M Keseru
© 2021 Meta ULC. All rights reserved